ADAP
Adaptimmune Therapeutics

9,810
Loading...
Loading...
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
506

Frequently Asked Questions

What is Market Cap of Adaptimmune Therapeutics Plc - ADR?
What is the 52-week high for Adaptimmune Therapeutics Plc - ADR?
What is the 52-week low for Adaptimmune Therapeutics Plc - ADR?
What is Adaptimmune Therapeutics Plc - ADR stock price today?
What was Adaptimmune Therapeutics Plc - ADR stock price yesterday?
What is the PE ratio of Adaptimmune Therapeutics Plc - ADR?
What is the Price-to-Book ratio of Adaptimmune Therapeutics Plc - ADR?
What is the 50-day moving average of Adaptimmune Therapeutics Plc - ADR?
How many employess does Adaptimmune Therapeutics Plc - ADR has?

Latest ADAP News

View

Advertisement|Remove ads.

Advertisement|Remove ads.